Výsledky vyhledávání

Akademický článek

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.

Autor: Reinal I; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain., Ontoria-Oviedo I; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain., Selva M; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain., Casini M; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain., Peiró-Molina E; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain.; Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain., Fambuena-Santos C; ITACA Institute, Universitat Politècnica de València, 46026 Valencia, Spain., Climent AM; ITACA Institute, Universitat Politècnica de València, 46026 Valencia, Spain., Balaguer J; Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.; Transtational Research in Cancer Unit-Pediatric Oncology, Health Research Institute Hospital La Fe, 46026 Valencia, Spain., Cañete A; Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.; Transtational Research in Cancer Unit-Pediatric Oncology, Health Research Institute Hospital La Fe, 46026 Valencia, Spain.; Department of Pediatrics, University of Valencia, 46010 Valencia, Spain., Mora J; Oncology Service, Hospital Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain., Raya Á; Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Program for Clinical Translation of Regenerative Medicine in Catalonia-P-[CMRC], L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Carlos III Institute of Health, 28029 Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain., Sepúlveda P; Regenerative Medicine and Heart Transplantation Unit, Health Research Institute Hospital la Fe, 46026 Valencia, Spain.; Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.; Department of Pathology, University of Valencia, 46010 Valencia, Spain.

Publikováno v: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 Jul 03; Vol. 12 (7). Date of Electronic Publication: 2023 Jul 03.

Zobrazit plný text záznamu

miR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia

Autor: Sánchez-Sánchez R, Gómez-Ferrer M, Reinal I, Buigues M, Villanueva-Bádenas E, Ontoria-Oviedo I, Hernándiz A, González-King H, Peiró-Molina E, Dorronsoro A, Sepúlveda P

Publikováno v: Frontiers in Cell and Developmental Biology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) are an emerging alternative to cell-based therapies to treat many diseases. However, the complexity of producing homogeneous populations of EVs in sufficient amount hampers th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::804f0486f336f728f68df2e7817a15c0
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14500

Zobrazit plný text záznamu

Akademický článek

MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats.

Autor: Sánchez-Sánchez R; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Reinal I; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Peiró-Molina E; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Buigues M; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Tejedor S; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Hernándiz A; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Selva M; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Hervás D; Data Science Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Cañada AJ; Data Science Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Dorronsoro A; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Santaballa A; Clinical and Translational Research in Cancer, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Salvador C; Clinical and Translational Research in Cancer, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain., Caiment F; Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, 6211 LK Maastricht, The Netherlands., Kleinjans J; Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, 6211 LK Maastricht, The Netherlands., Martínez-Dolz L; Clinical and Translational Research Group in Cardiology, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain., Moscoso I; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.; Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Department of Cardiology and Coronary Unit, Institute of Biomedical Research (IDIS-SERGAS), University Clinical Hospital of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Lage R; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.; Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Department of Cardiology and Coronary Unit, Institute of Biomedical Research (IDIS-SERGAS), University Clinical Hospital of Santiago de Compostela, 15782 Santiago de Compostela, Spain., González-Juanatey JR; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.; Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Department of Cardiology and Coronary Unit, Institute of Biomedical Research (IDIS-SERGAS), University Clinical Hospital of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Panadero J; IGENOMIX, 46980 Valencia, Spain., Aparicio-Puerta E; Chair for Clinical Bioinformatics, Saarland University, 66123 Saarbrücken, Germany., Bernad A; Department of Immunology & Oncology, National Center for Biotechnology (CNB-CSIC), Campus de Cantoblanco de la Universidad Autónoma de Madrid, 28049 Madrid, Spain., Sepúlveda P; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.

Publikováno v: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2022 Sep 30; Vol. 11 (10). Date of Electronic Publication: 2022 Sep 30.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání